Manufacturer record
SVR Healthcare: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by SVR Healthcare (Himachal Pradesh) were declared Not of Standard Quality between March 2019 and September 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to SVR Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefixime Tablets IP 200 mg | DL-134Mfg 2024-10 · Exp 2026-11 | AssayAssay | RDTL, ChandigarhCDSCO lab | Sep 2025 |
| Amoxycillin Trihydrate Dispersible Tablets IP 250 mg | DL-58Mfg 2024-10 · Exp 2026-09 | Disintegration test, Uniformity of dispersion and AssayAssay | RDTL, ChandigarhCDSCO lab | Sep 2025 |
| Omeford - 40 | SNT-220421Mfg 2022-09 · Exp 2024-08 | THE CONTENT OF OMEPRAZOLE IN THE SAMPLE IS LESS (l.e. 40.84% OF LABELLED AMOUNT) THAN THE SCHEDULE V LIMITSLabelling | State Lab MaharashtraState lab | Jun 2024 |
| CEFUROXIME AXETIL TABLETS I.P. (AXTUM-250) | SBT-16732Mfg 2017-12 · Exp 2019-11 | DissolutionDissolution | RDTL GuwahatiState lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.